Clinical Trial Update: Chemo-immunotherapy Plus Thoracic Radiotherapy in Extensive Stage Small-cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating chemo-immunotherapy plus thoracic radiotherapy for extensive-stage small-cell lung cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Snippet

Sponsor: Norwegian University of Science and Technology | Conditions: Small-cell Lung Cancer | Phase 3 | Status: TERMINATED